Skip to main content

Aspiriant, LLC

SEC CIK
0001433541
Latest filing
Jul 20, 2026

ABT holding history

Abbott Laboratories in every 13F filed by Aspiriant, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ABT overviewAll 13F holders of ABTFull Q2 2026 holdings

Shares (Q2 2026)
18,512
Value
$1.68M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ABT by Aspiriant, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202618,512$1.68M<0.1%+793+4.5%AddedHolders
Q1 202617,719$1.82M0.1%+981+5.9%AddedHolders
Q4 202516,738$2.10M0.1%−315−1.8%ReducedHolders
Q3 202517,053$2.28M0.1%−206−1.2%ReducedHolders
Q2 202517,259$2.35M0.1%−2,001−10.4%ReducedHolders
Q1 202519,260$2.55M0.1%−674−3.4%ReducedHolders
Q4 202419,934$2.25M0.1%−384−1.9%ReducedHolders
Q3 202420,318$2.32M0.1%−33−0.2%ReducedHolders
Q2 202420,351$2.11M0.1%−752−3.6%ReducedHolders
Q1 202421,103$2.40M0.1%−179−0.8%ReducedHolders
Q4 202321,282$2.34M0.1%−298−1.4%ReducedHolders
Q3 202321,580$2.09M0.1%−616−2.8%ReducedHolders
Q2 202322,196$2.42M0.1%+3,080+16.1%AddedHolders
Q1 202319,116$1.94M0.1%−113−0.6%ReducedHolders
Q4 202219,229$2.11M0.1%−386−2.0%ReducedHolders
Q3 202219,615$1.90M0.1%+445+2.3%AddedHolders
Q2 202219,170$2.08M0.1%+102+0.5%AddedHolders
Q1 202219,068$2.26M0.1%−768−3.9%ReducedHolders
Q4 202119,836$2.79M0.1%+1,831+10.2%AddedHolders
Q3 202118,005$2.13M0.1%−753−4.0%ReducedHolders
Q2 202118,758$2.17M0.1%+444+2.4%AddedHolders
Q1 202118,314$2.19M0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.